Drug Trial Radar · NCT06218771
A Study of TQB3454 Tablets in Patients With Blood Tumors
Last checked: Nov 19, 2026Latest source record: Jan 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
80
Planned (sponsor's estimate)
Start
Jul 10, 2023
Primary completion
Jun 2025
Study completion Dec 2025
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 23, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to evaluate the safety of TQB3454 tablets in patients with acute myeloid leukemia and myelodysplastic syndrome, and determine the phase II recommended dose.
Conditions
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
Interventions
TQB3454 TabletsDrug
TQB3454 Tablets is a selective isocitrate dehydrogenase 1 (IDH1) mutation inhibitor
Primary outcomes
What the sponsor says the trial is designed to measure.
- The rate of all adverse events (AEs), serious adverse events (SAEs)Time frame: Up to 80 weeks
- The severity of all adverse events (AEs), serious adverse events (SAEs)Time frame: Up to 80 weeks
- Incidence of abnormal laboratory valuesTime frame: Up to 80 weeks
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical College
Bengbu, Anhui, China · Recruiting
Cangzhou people's Hospital
Cangzhou, Hebei, China · Recruiting
The Affiliated Hospital of Chengde Medical College
Chengde, Hebei, China · Recruiting
Henan Cancer Hospital
Zhengzhou, Henan, China · Recruiting
Union Hospital Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China · Recruiting
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China · Recruiting
Wuxi People's Hospital
Wuxi, Jiangsu, China · Recruiting
Affiliated Hospital of Binzhou Medical College
Binzhou, Shandong, China · Recruiting
Yantai Mountain Hospital
Yantai, Shandong, China · Recruiting
Yantai Yuhuangding Hospital
Yantai, Shandong, China · Recruiting
Shanghai Tongren Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Huashan Hospital affiliated to Fudan University
Shanghai, Shanghai Municipality, China · Recruiting
Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China · Recruiting
Shanghai Sixth People's Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China · Recruiting
West China Hospital, Sichuan University
Chengdu, Sichuan, China · Recruiting
Hospital of Hematology, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.